How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
Fuente:
Redalyc
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Centro de investigaciones y Publicaciones Farmacéuticas
2012
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1876458736745185280 |
|---|---|
| author | Pieter DYLST |
| author_facet | Pieter DYLST |
| contents | How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing? Pieter DYLST Arnold VULTO Steven SIMOENS Medicina Fees Drugs Europe Generic Pharmacists Generic medicines can generate larger savings to health care budgets when their use is supported by incentives on both the supply-side and the demandside. Pharmacists¿ remuneration is one factor influencing the dispensing of generic medicines. Objective: The aim of this article is to provide an overview of different pharmacist remuneration systems for generic medicines in Europe, with a view to exploring how pharmacist remuneration systems can contribute to generic medicine dispensing. Methods: Data were obtained from a literaturereview, a Master thesis in Pharmaceutical Care at the Catholic University of Leuven and a mailing sent to all members of the Pharmaceutical Group of the European Union with a request for information about the local remuneration systems of community pharmacists and the possible existence of reports on discounting practices. Results: Pharmacists remuneration in most European countries consists of the combination of a fixed fee per item and a certain percentage of the acquisition cost or the delivery price of the medicines. This percentage component can be fixed, regressive or capped for very high-cost medicines and acts as a disincentive for dispensing generic medicines. Discounting for generic medicines is common practice in several European countries but information on this practice tends to be confidential. Nevertheless, data for Belgium, France, the Netherlands and United Kingdomindicated that discounting percentages varied from 10% to 70% of the wholesale selling price.Conclusion: Pharmacists can play an important role in the development of a generic medicinesmarket. Pharmacists should not be financially penalized for dispensing generic medicines.Therefore, their remuneration should move towards a fee-for-performance remuneration instead of a price-dependent reimbursement which is currently used in many European countries. Such a fee-forperformance remuneration system provides a stimulus for generic medicines dispensing as pharmacists are not penalized for dispensing them *Pieter DYLST. PharmD, PhD-candidate. Research Centre for Pharmaceutical Care & Pharmaco-economics,K U Leuven. Leuven (Belgium). Arnold VULTO. PharmD, PhD. Professor Hospital Pharmacy & Practical Therapeutics. Hospital Pharmacy, Erasmus University Medical Centre. Rotterdam (TheNetherlands). Steven SIMOENS. MSc. Professor Pharmaco-economics. Research Centre for Pharmaceutical Care & Pharmacoeconomics, K U Leuven. Leuven (Belgium). but also needs to account for the loss of income to pharmacists from prohibiting discounting practices. 2012 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69023722002 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.1 Vol.10 |
| format | Artículo científico |
| id | redalyc_69023722002 |
| institution | Redalyc |
| language | en |
| publishDate | 2012 |
| publisher | Centro de investigaciones y Publicaciones Farmacéuticas |
| spellingShingle | How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing? Pieter DYLST Medicina Fees Drugs Europe Generic Pharmacists How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing? Pieter DYLST Arnold VULTO Steven SIMOENS Medicina Fees Drugs Europe Generic Pharmacists Generic medicines can generate larger savings to health care budgets when their use is supported by incentives on both the supply-side and the demandside. Pharmacists¿ remuneration is one factor influencing the dispensing of generic medicines. Objective: The aim of this article is to provide an overview of different pharmacist remuneration systems for generic medicines in Europe, with a view to exploring how pharmacist remuneration systems can contribute to generic medicine dispensing. Methods: Data were obtained from a literaturereview, a Master thesis in Pharmaceutical Care at the Catholic University of Leuven and a mailing sent to all members of the Pharmaceutical Group of the European Union with a request for information about the local remuneration systems of community pharmacists and the possible existence of reports on discounting practices. Results: Pharmacists remuneration in most European countries consists of the combination of a fixed fee per item and a certain percentage of the acquisition cost or the delivery price of the medicines. This percentage component can be fixed, regressive or capped for very high-cost medicines and acts as a disincentive for dispensing generic medicines. Discounting for generic medicines is common practice in several European countries but information on this practice tends to be confidential. Nevertheless, data for Belgium, France, the Netherlands and United Kingdomindicated that discounting percentages varied from 10% to 70% of the wholesale selling price.Conclusion: Pharmacists can play an important role in the development of a generic medicinesmarket. Pharmacists should not be financially penalized for dispensing generic medicines.Therefore, their remuneration should move towards a fee-for-performance remuneration instead of a price-dependent reimbursement which is currently used in many European countries. Such a fee-forperformance remuneration system provides a stimulus for generic medicines dispensing as pharmacists are not penalized for dispensing them *Pieter DYLST. PharmD, PhD-candidate. Research Centre for Pharmaceutical Care & Pharmaco-economics,K U Leuven. Leuven (Belgium). Arnold VULTO. PharmD, PhD. Professor Hospital Pharmacy & Practical Therapeutics. Hospital Pharmacy, Erasmus University Medical Centre. Rotterdam (TheNetherlands). Steven SIMOENS. MSc. Professor Pharmaco-economics. Research Centre for Pharmaceutical Care & Pharmacoeconomics, K U Leuven. Leuven (Belgium). but also needs to account for the loss of income to pharmacists from prohibiting discounting practices. 2012 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69023722002 en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.1 Vol.10 |
| title | How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing? |
| topic | Medicina Fees Drugs Europe Generic Pharmacists |
| url | https://www.redalyc.org/articulo.oa?id=69023722002 |